An experimental amino acid peptide that targets neurofibrillary tangles appears to improve memory in patients with amnesic mild cognitive impairment. Medscape Medical News
The FDA has approved glycopyrrolate oral solution for the treatment of patients aged 3 to 16 years with chronic severe drooling associated with neurologic conditions, such as cerebral palsy. Medscape Medical News